Navigation Links
Agilent Technologies and Shimadzu Enable Control of Each Other’s GC Instruments in Their Respective Chromatographic Data Systems
Date:8/25/2014

(PRWEB) August 25, 2014

Agilent Technologies, Inc. and Shimadzu Corp. today announced the release of GC instrument control for their respective Chromatography Data Systems (CDS). This provides customers in analytical laboratories with more freedom of choice when selecting a chromatography data system.

Agilent has released drivers for Shimadzu GC-2010, GC-2010 Plus and GC-2014 integrating to Agilent’s OpenLAB CDS, and Shimadzu has released drivers to control Agilent 6890, 6850, 7820 and 7890 GC instruments in Shimadzu’s LabSolutions. These releases are the result of the joint collaboration--employing RapidControl (RC.NET) instrument drivers--announced in May 2013 to preserve customers’ investments in workflows and operating procedures.

“Agilent continues to follow an open systems approach for the laboratory to deliver value to our customers,” said Bruce von Herrmann, vice president and general manager of Agilent’s Software and Informatics Business. “To reduce costs and enhance the customer experience, we are working with other manufacturers like Shimadzu to enable full and reliable control of lab instrumentation from any CDS. These new releases demonstrate that Rapid Control is the predominant industry standard for analytical instrument control.”

"At Shimadzu, we continue to deploy industry standard drivers for instrument control to provide flexible instrumentation and software solutions for our customers," said Masahito Ueda, Shimadzu general manager of GC & TA Business Unit, Analytical & Measuring Instruments Division. "The adoption and support of RC.NET drivers provide a more integrated solution to customers who require a single CDS product to support seamless multi-vendor control of all instruments in their laboratory."

This move expands control of each other’s instruments to gas chromatography. Since mid-2013, Agilent’s OpenLAB CDS, has supported Shimadzu's Nexera and Prominence HPLC lines and Shimadzu's LabSolutions CDS has supported Agilent's 1100, 1200, 1260 and 1290 series instruments.

For more information about Shimadzu's LabSolutions chromatography systems, visit http://www.shimadzu.com/an/data-net.

For more information about OpenLAB CDS, visit Agilent’s Software & Informatics website.

About Shimadzu Corporation
Founded in 1875, Shimadzu Corporation, a leader in the development of advanced technologies, has a distinguished history of innovation built on the foundation of contributing to society through science and technology. Shimadzu maintains a global network of sales, service, technical support and applications centers on six continents, and has established long-term relationships with a host of highly trained distributors located in over 100 countries. For more information, visit http://www.shimadzu.com.

About Agilent Technologies
Agilent Technologies Inc. is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at http://www.agilent.com.

On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business. The new company is named Keysight Technologies, Inc. The separation is expected to be completed in early November 2014.

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at http://www.agilent.com/go/news.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12112730.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon
2. Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
3. Ocular Drug Delivery Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
4. BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite
5. JH Technologies Brings an Expanded Level of Microscope and Imaging Expertise to Industrial Customers in Southern California
6. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results
7. Pairing old technologies with new for next-generation electronic devices
8. Advancements in OMIC Technologies Drive the Global Bioinformatics Market, According to New Report by Global Industry Analysts, Inc.
9. Pairing old technologies with new for next generation electronic devices
10. Cell Separation Technologies Market Expected to Reach USD 3.3 Billion Globally in 2019: Transparency Market Research
11. Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... and scientists from around the world, was today awarded the "Best Science & ... based entirely on merit and decided upon by a dedicated team of researchers ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
(Date:1/18/2017)... -- According to a new market research report "In situ Hybridization ... End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to ... by 2021 from USD 557.1 Million in 2016, growing at a CAGR of ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/19/2017)... , Jan. 19, 2017 ... user experience and security for consumer electronics, and ... payment processing systems and cybersecurity solutions, today announced ... enterprises and financial institutions worldwide to bolster security ... the end-to-end secure user authentication platforms they offer, ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
Breaking Biology News(10 mins):